Abstract
The early days of the Covid-19 pandemic was a time of crisis filled with fear and confusion among marketing professionals as well as consumers. With the stay-at-home orders and resulting changes in consumer behaviors, marketers, including healthcare service providers and pharma product companies, changed their messaging and advertising outreach strategies. But was it even ethical for healthcare service providers and pharma product companies to market their services and products during this period of fear and confusion? In the following article, the authors review many of the changes in the management, strategies, and messaging of the integrated marketing communication for healthcare services and pharma companies during the pandemic as well as the ethical considerations resulting from these changes. The article concludes with recommendations on how to ethically market healthcare services and pharma products during future pandemics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
